FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214531512> ?p ?o ?g. }

• W4214531512 endingPage "1340" @default.
• W4214531512 startingPage "1333" @default.
• W4214531512 abstract "Triazines are in great interest for their potential to mimic nucleoside analog compounds. Three different isomers exist including 1,2,3-triazine, 1,3,5-triazine (s-triazine) and 1,2,4-triazine. All of these skeletons were investigated. Among them, 5,6-diaryltriazines were previously tested on MCF7 and other tumor cell lines. In this study, we have synthesized and characterized 9 novel 5,6-diaryl-1,2,4-triazine derivatives (4a-i) using 1HNMR, 13CNMR, and HRMS spectra. Contributing to the previous data, we tested our compounds on U87MG, C6 and SH-SY5Y cell lines along with MCF7. We evaluated if these compounds affect CNS tumors in vitro, which cell lines have different protein profiles from MCF7 and mainly nucleosides are used as their antiproliferative agents. Briefly, compounds showed good antitumor activity on the C6 cell line with up to 50% inhibition for 7 of 9 compounds (4b, 4d-i) at 50 μM. Additionally, compounds showed moderate activity on U87MG glioblastomas, compound 4a was the most active with 29.68 μM IC50. Compounds did not show significant activity on SH-SY5Y cells. Cytotoxicity evaluation gave the results that the synthesized compounds show moderate cytotoxicity on NIH-3T3 and severe cytotoxicity on HEK 293. The study leads the investigations of triazines with glioma cell lines." @default.
• W4214531512 created "2022-03-02" @default.
• W4214531512 creator A5027641358 @default.
• W4214531512 creator A5029275257 @default.
• W4214531512 creator A5031016240 @default.
• W4214531512 creator A5048597321 @default.
• W4214531512 creator A5059395348 @default.
• W4214531512 creator A5086664655 @default.
• W4214531512 creator A5087222481 @default.
• W4214531512 creator A5090129265 @default.
• W4214531512 date "2022-03-06" @default.
• W4214531512 modified "2023-09-28" @default.
• W4214531512 title "Synthesis and in vitro antitumor activities of novel thioamide substituted piperazinyl‐1,2, <scp>4‐triazines</scp>" @default.
• W4214531512 cites W1982626083 @default.
• W4214531512 cites W1986680732 @default.
• W4214531512 cites W2029557430 @default.
• W4214531512 cites W2032798411 @default.
• W4214531512 cites W2059719129 @default.
• W4214531512 cites W2077529014 @default.
• W4214531512 cites W2081980323 @default.
• W4214531512 cites W2087047062 @default.
• W4214531512 cites W2123891584 @default.
• W4214531512 cites W2124142551 @default.
• W4214531512 cites W2331705543 @default.
• W4214531512 cites W2742232675 @default.
• W4214531512 cites W2742654522 @default.
• W4214531512 cites W2762858701 @default.
• W4214531512 cites W2792926295 @default.
• W4214531512 cites W2896916516 @default.
• W4214531512 cites W2912993657 @default.
• W4214531512 cites W2972059736 @default.
• W4214531512 cites W3013446577 @default.
• W4214531512 cites W3021909056 @default.
• W4214531512 cites W3097323536 @default.
• W4214531512 cites W3115872106 @default.
• W4214531512 cites W3119005666 @default.
• W4214531512 doi "https://doi.org/10.1002/jhet.4470" @default.
• W4214531512 hasPublicationYear "2022" @default.
• W4214531512 type Work @default.
• W4214531512 citedByCount "4" @default.
• W4214531512 countsByYear W42145315122022 @default.
• W4214531512 countsByYear W42145315122023 @default.
• W4214531512 crossrefType "journal-article" @default.
• W4214531512 hasAuthorship W4214531512A5027641358 @default.
• W4214531512 hasAuthorship W4214531512A5029275257 @default.
• W4214531512 hasAuthorship W4214531512A5031016240 @default.
• W4214531512 hasAuthorship W4214531512A5048597321 @default.
• W4214531512 hasAuthorship W4214531512A5059395348 @default.
• W4214531512 hasAuthorship W4214531512A5086664655 @default.
• W4214531512 hasAuthorship W4214531512A5087222481 @default.
• W4214531512 hasAuthorship W4214531512A5090129265 @default.
• W4214531512 hasConcept C109316439 @default.
• W4214531512 hasConcept C116073593 @default.
• W4214531512 hasConcept C178790620 @default.
• W4214531512 hasConcept C185592680 @default.
• W4214531512 hasConcept C202751555 @default.
• W4214531512 hasConcept C21951064 @default.
• W4214531512 hasConcept C2776303721 @default.
• W4214531512 hasConcept C2776543447 @default.
• W4214531512 hasConcept C2777650178 @default.
• W4214531512 hasConcept C2777752497 @default.
• W4214531512 hasConcept C2778218704 @default.
• W4214531512 hasConcept C54355233 @default.
• W4214531512 hasConcept C55493867 @default.
• W4214531512 hasConcept C71240020 @default.
• W4214531512 hasConcept C81885089 @default.
• W4214531512 hasConcept C86803240 @default.
• W4214531512 hasConceptScore W4214531512C109316439 @default.
• W4214531512 hasConceptScore W4214531512C116073593 @default.
• W4214531512 hasConceptScore W4214531512C178790620 @default.
• W4214531512 hasConceptScore W4214531512C185592680 @default.
• W4214531512 hasConceptScore W4214531512C202751555 @default.
• W4214531512 hasConceptScore W4214531512C21951064 @default.
• W4214531512 hasConceptScore W4214531512C2776303721 @default.
• W4214531512 hasConceptScore W4214531512C2776543447 @default.
• W4214531512 hasConceptScore W4214531512C2777650178 @default.
• W4214531512 hasConceptScore W4214531512C2777752497 @default.
• W4214531512 hasConceptScore W4214531512C2778218704 @default.
• W4214531512 hasConceptScore W4214531512C54355233 @default.
• W4214531512 hasConceptScore W4214531512C55493867 @default.
• W4214531512 hasConceptScore W4214531512C71240020 @default.
• W4214531512 hasConceptScore W4214531512C81885089 @default.
• W4214531512 hasConceptScore W4214531512C86803240 @default.
• W4214531512 hasIssue "8" @default.
• W4214531512 hasLocation W42145315121 @default.
• W4214531512 hasOpenAccess W4214531512 @default.
• W4214531512 hasPrimaryLocation W42145315121 @default.
• W4214531512 hasRelatedWork W1978877890 @default.
• W4214531512 hasRelatedWork W1996671351 @default.
• W4214531512 hasRelatedWork W2002338330 @default.
• W4214531512 hasRelatedWork W2005403524 @default.
• W4214531512 hasRelatedWork W2017680051 @default.
• W4214531512 hasRelatedWork W2035982103 @default.
• W4214531512 hasRelatedWork W2038008830 @default.
• W4214531512 hasRelatedWork W2231440738 @default.
• W4214531512 hasRelatedWork W2413561102 @default.
• W4214531512 hasRelatedWork W4214531512 @default.
• W4214531512 hasVolume "59" @default.

• next